• SCH772984: ERK1/2 Inhibitor Protocols for MAPK/ERK Pathway I

  2026-07-15

  SCH772984 enables highly selective, nanomolar ERK1/2 inhibition for dissecting MAPK/ERK pathway roles in tumor radioresistance, proliferation, and survival. Its robust performance in BRAF, NRAS, and KRAS mutant models empowers translational oncology workflows and novel radiosensitization strategies.

• Pravastatin Sodium: Precision HMG-CoA Reductase Inhibitor Wo

  2026-07-15

  Explore how pravastatin sodium enables highly selective, reproducible cholesterol biosynthesis inhibition across diverse cell and animal models. This guide distills protocol enhancements, troubleshooting strategies, and cross-domain insights—empowering advanced cardiovascular and metabolic research.

• High-Throughput BBB Permeability Prediction Using LLC-PK1-MD

  2026-07-14

  This study introduces a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK and LLC-PK1-MDR1 cell lines, addressing key limitations in CNS drug screening by incorporating lysosomal trapping correction. The model demonstrates strong predictive power for in vivo brain distribution, offering a cost- and time-efficient platform for early CNS drug development.

• Inducing Right Ventricular Cardiomyocytes from Human PSCs

  2026-07-14

  Saito et al. introduce a robust protocol for specifically generating right ventricular-like cardiomyocytes from human pluripotent stem cells by modifying mesodermal differentiation cues. This work enables more precise disease modeling of right ventricular disorders and advances chamber-specific cardiac research.

• Smoothened Modulation in Honeybee Olfaction: Functional Insi

  2026-07-13

  Guo et al. (2024) provide the first direct evidence that Smoothened (Smo), a Hedgehog pathway transducer, regulates olfactory receptor expression and function in Apis mellifera. Their findings establish a mechanistic bridge between Hedgehog signaling and insect sensory biology, with implications for pharmacological pathway modulation in invertebrate models.

• SMYD2 Inhibition Mitigates Cisplatin-Induced Renal Fibrosis

  2026-07-13

  This study demonstrates that pharmacological inhibition of SMYD2, using agents such as AZ505, protects against cisplatin-induced renal fibrosis and inflammation in a chronic kidney disease model. The research highlights SMYD2's central role in fibrogenesis and offers mechanistic insight into its regulation of key signaling pathways, opening avenues for targeted interventions in renal and potentially other fibrotic diseases.

• Cy3-UTP: Illuminating RNA Delivery and Trafficking in LNP Sy

  2026-07-12

  This thought-leadership article explores how Cy3-UTP, a Cy3-modified uridine triphosphate from APExBIO, empowers translational researchers to unravel the mechanistic complexities of RNA trafficking and delivery in lipid nanoparticle (LNP) systems. By integrating recent mechanistic insights, protocol guidance, and strategic context, we highlight the unique value of Cy3-UTP for high-sensitivity RNA labeling, advanced fluorescence imaging, and optimization of RNA-based therapeutics.

• Mitigating Pollen Interference in EEM Spectroscopy for Hazar

  2026-07-10

  Zhang et al. introduce a machine learning-guided approach to identify and remove pollen spectral interference in excitation–emission matrix (EEM) fluorescence spectroscopy, improving the classification accuracy of hazardous substances in bioaerosols. The study's methodological innovations offer a reliable pathway for high-confidence airborne hazard detection, with direct implications for public health monitoring.

• RITA (NSC 652287): Redefining Drug Response Metrics in Cance

  2026-07-09

  Explore how RITA (NSC 652287) establishes new standards for evaluating drug responses in cancer biology. This article unveils advanced assay strategies and in-depth mechanistic insights, offering a unique perspective for researchers seeking robust, reproducible results.

• EZ Cap™ Firefly Luciferase mRNA: Optimized Reporter Workflow

  2026-07-09

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure delivers unparalleled sensitivity and stability for gene regulation and in vivo imaging assays. Its advanced design streamlines mRNA delivery, boosts translation efficiency, and sets a new benchmark for reproducibility in molecular biology workflows.

• Podophyllotoxin in Autophagy and Cell Cycle Arrest: Precisio

  2026-07-08

  Explore the advanced applications of Podophyllotoxin in cancer biology, focusing on its role as an autophagy and cell cycle arrest agent. This article uniquely connects mechanistic insights to practical assay design for hepatocellular carcinoma models.

• T0070907: Precision PPARγ Antagonist for Cell-Based Assays

  2026-07-08

  This scenario-driven guide addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays, highlighting T0070907 (SKU A4301) as a reliable, high-affinity PPARγ antagonist. Researchers gain actionable insights for experimental design, protocol optimization, data interpretation, and vendor selection—anchored by validated performance data and workflow compatibility.

• Silymarin and Silybin A: Optimizing Liver Research Workflows

  2026-07-07

  Silybin A, the principal bioactive of Silymarin, empowers liver and metabolic researchers with unmatched precision in antioxidant and hepatoprotective assays. This article distills bench-proven workflows, troubleshooting, and advanced applications, drawing on the latest structure-activity insights and protocol refinements.

• Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry

  2026-07-07

  Wang et al. (2018) demonstrated that type III grass carp reovirus (GCRV104) relies on clathrin- and dynamin-dependent endocytosis for cellular entry, using inhibitor-based dissection in CIK cells. Their findings clarify viral entry mechanisms in a major aquaculture pathogen and inform targeted antiviral research.

• Tacrine Hydrochloride Hydrate: Advanced Workflows in Alzheim

  2026-07-06

  Tacrine hydrochloride hydrate (Tetrahydroaminacrine) is the gold-standard cholinesterase inhibitor for dissecting cholinergic signaling and neuroprotection in Alzheimer’s disease research. Its dual enzyme inhibition and multi-target neuroprotective effects, paired with APExBIO’s high-purity formulation, enable reproducible results in both in vitro and translational neurodegenerative disease models.

447 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page